BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35576899)

  • 1. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
    Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
    Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
    Front Immunol; 2021; 12():700224. PubMed ID: 34456912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of the International Prognosis Prediction Model of IgA Nephropathy.
    Hu L; Fang Y; Huang J; Liu J; Xu L; He W
    Ren Fail; 2024 Dec; 46(1):2313174. PubMed ID: 38345077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C; Wang AY; Li G; Wang L
    BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
    Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation of the International IgA Nephropathy Prediction Tool.
    Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.
    Li H; Lu W; Xie X; Wang Y; Dang X; Sun J; Jiang H
    Kidney Blood Press Res; 2024; 49(1):20-26. PubMed ID: 38048756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
    Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
    Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
    Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
    Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.